Contact this trialFirst, we need to learn more about you.
MEK Inhibitor
Trametinib with/without Radiation for Brain Metastasis
Recruiting1 awardPhase 1
Chicago, Illinois
This trial is testing the effects of a drug called trametinib, with or without radiation therapy, in patients with brain metastases. Trametinib may stop the growth of tumor cells by blocking enzymes needed for cell growth. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving trametinib with radiation therapy may be a better treatment for brain metastases.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service